UFM
DALS

Ursa Fund Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Ursa Fund Management’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,000
Closed -$243K – 55
2022
Q1 		$243K Buy
+25,000
New +$241K 0.1% 59

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ursa Fund Management's DALS Position: Q2 2022 in Review

Ursa Fund Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2022, closing a stake of 25,000 shares — an estimated $243K sold.

Ursa Fund Management first reported a position in DALS in Q1 2022 and held it in 1 quarter. The position peaked at $243K in Q1 2022. 45 funds tracked by Wall St. Rank hold DALS as of Q2 2022.

  • Ursa Fund Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ursa Fund Management sold 25,000 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $243K.
  • Ursa Fund Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 1 quarter.
  • Ursa Fund Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $243K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Ursa Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.